Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trialsBMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5600 (Published 17 October 2016) Cite this as: BMJ 2016;355:i5600
In this Research paper (BMJ 2015;350:h1618, doi:10.1136/bmj.h1618), an error has been made in the affiliations. Professor Gianfranco Parati’s affiliation should read as follows: Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano, Milan, Italy and Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/.